Portolan Capital Management’s Covisint Corporation COVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-992,908
Closed -$1.99M 128
2016
Q1
$1.99M Sell
992,908
-2,079,221
-68% -$4.22M 0.27% 99
2015
Q4
$7.68M Buy
3,072,129
+123,347
+4% +$279K 0.97% 27
2015
Q3
$6.34M Buy
2,948,782
+673,182
+30% +$1.85M 0.84% 48
2015
Q2
$7.44M Buy
2,275,600
+903,815
+66% +$2.14M 1.04% 32
2015
Q1
$2.79M Buy
1,371,785
+15,250
+1% +$35.6K 0.51% 76
2014
Q4
$3.6M Buy
1,356,535
+1,097,510
+424% +$3.14M 0.72% 58
2014
Q3
$1.07M Buy
259,025
+88,369
+52% +$397K 0.24% 96
2014
Q2
$829K Buy
170,656
+17,872
+12% +$112K 0.18% 104
2014
Q1
$1.12M Buy
+152,784
New +$1.54M 0.26% 106

Other funds holding COVS

Portolan Capital Management's COVS Position: Q2 2016 in Review

Portolan Capital Management sold out of Covisint Corporation (COVS) in Q2 2016, closing a stake of 992,908 shares — an estimated $1.99M sold.

Portolan Capital Management first reported a position in COVS in Q1 2014 and held it in 9 quarters. The position peaked at $7.68M in Q4 2015. 64 funds tracked by Wall St. Rank hold COVS as of Q2 2016.

  • Portolan Capital Management reported no remaining Covisint Corporation position as of Q2 2016 after selling out during the quarter.
  • Portolan Capital Management sold 992,908 Covisint Corporation shares in Q2 2016, an estimated $1.99M.
  • Portolan Capital Management first reported a position in Covisint Corporation in Q1 2014 and held it in 9 quarters.
  • Portolan Capital Management's Covisint Corporation position peaked at $7.68M in Q4 2015.
  • 64 funds tracked by Wall St. Rank held Covisint Corporation as of Q2 2016.

Based on Portolan Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.